IBM Watson to Boost Pharma R&D and Reduce Costs

  IBM Watson is taking research to levels of speed unreachable by humans IBM announced last week the next step in Watson Discovery Advisor’s cognitive computing capabilities. Now available as a cloud service, it is already showing its potential to help research teams in all sectors accelerate research and discovery processes, by quickly analysing data in millions of scientific papers …

Moving Towards Personalised Medicine with Big Data Strategies

  The use of Big Data strategies is thought to have the potential to help physicians and scientists move closer to treating individuals, rather than diseases. Developing treatments that are tailored to an individual’s history and sensitivities presents many challenges, and will only be possible within a digital health care system. An article from 20 January 2011 in the U.S. News & World …

intel smartwatch parkinsons

Intel Develops Big Data Tools and Wearables to Diagnose and Study Parkinson’s

Intel has announced a partnership with the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to develop Big Data tools that will hopefully help diagnose this degenerative disorder earlier, and find a cure. Wearable sensors under the form of smartwatches could be the biggest progress of the last 200 years in terms of assessment tools available to diagnose and study …

Download: Kinapse on New Data Analytics for Pharma and Healthcare

An interview with Stephen Doogan on data integration and analytics for drug evaluation and patient experience McKinsey has predicted big data could reduce research and development costs for pharmaceutical makers by $40 billion to $70 billion. New analytics strategies are now changing companies’ ability to integrate, harmonize, derive and cross-validate insights from disconnected data at scale. Pharma companies who team up with …

big data big pharma

Announcing The Marriage of Big Pharma and Big Data

Novartis teams up with Google to develop “smart” lens This week a partnership between Goggle and Novartis has been announced, for the development of a “smart” contact lens to help diabetics track their blood sugar levels. This is the first big partnership made public between big pharma and big data to work together to revolutionise chronic disease monitoring and treatment. …

privacy analytics pharma

Privacy Analytics releases solution to share anonymised clinical trials data

  A leading provider of data anonymisation solutions for the health care industry has announced the release of a new solution that enables companies to share clinical trials data while protecting the privacy of individual participants. Privacy Analytics’ Open Clinical Trials Data Review identifies privacy gaps in sharing clinical trials data, by relying on the company’s PARAT software, which automates …

big data in pharma

Big Data Analytics Companies: Competitors or Collaborators?

  An industry survey of 1,600 pharmacy professional, which reveals some very interesting trends in the way the industry perceives its future. The 971 who responded included managers (39 percent), directors (30 percent), consultants (10 percent), CEOs (9 percent), and sales reps (9 percent). Perhaps one of the most interesting revelations of this survey is that 59 percent of them …

project data sphere

Why you should share your clinical and patient records data

  Many pharmaceutical companies are now seeing the benefits of sharing clinical trial or patient data to create a pool of data where so far unidentified patterns might emerge. These practices require the standardisation of electronic records, and can be challenged by patient privacy concerns, but they can help us develop better treatments for diseases. As Michael Keiser, instructor at …